AAAAAA
Results:
1-23
|
Results: 23
Authors:
Judson, I
Radford, JA
Harris, M
Blay, JY
van Hoesel, Q
le Cesne, A
van Oosterom, AT
Clemons, MJ
Kamby, C
Hermans, C
Whittaker, J
di Paola, ED
Verweij, J
Nielsen, S
Citation: I. Judson et al., Randomised phase II trial of pegylated liposomal doxorubicin (DOXIL (R)/CAELYX (R)) versus doxorubicin in the treatment of advanced or metastatic soft tissue sarcoma: a study by the EORTC Soft Tissue and Bone Sarcoma Group, EUR J CANC, 37(7), 2001, pp. 870-877
Authors:
Howell, SJ
Radford, JA
Adams, JE
Smets, EMA
Warburton, R
Shalet, SM
Citation: Sj. Howell et al., Randomized placebo-controlled trial of testosterone replacement in men with mild Leydig cell insufficiency following cytotoxic chemotherapy, CLIN ENDOCR, 55(3), 2001, pp. 315-324
Authors:
Radford, JA
Lieberman, BA
Brison, DR
Smith, ARB
Critchlow, JD
Russell, SA
Watson, AJ
Clayton, JA
Harris, M
Gosden, RG
Shalet, SM
Citation: Ja. Radford et al., Orthotopic reimplantation of cryopreserved ovarian cortical strips after high-dose chemotherapy for Hodgkin's lymphoma, LANCET, 357(9263), 2001, pp. 1172-1175
Authors:
Brook, PF
Radford, JA
Shalet, SM
Joyce, AD
Gosden, RG
Citation: Pf. Brook et al., Isolation of germ cells from human testicular tissue for low temperature storage and autotransplantation, FERT STERIL, 75(2), 2001, pp. 269-274
Authors:
Blackhall, FH
Ranson, M
Radford, JA
Hancock, BW
Soukop, M
McGown, AT
Robbins, A
Halbert, G
Jayson, GC
Citation: Fh. Blackhall et al., A phase II trial of bryostatin 1 in patients with non-Hodgkin's lymphoma, BR J CANC, 84(4), 2001, pp. 465-469
Authors:
Nielsen, OS
Judson, I
van Hoesel, Q
le Cesne, A
Keizer, HJ
Blay, JY
van Oosterom, A
Radford, JA
Svancarova, L
Krzemienlecki, K
Hermans, C
van Glabbeke, M
Oosterhuis, JW
Verweij, J
Citation: Os. Nielsen et al., Effect of high-dose ifosfamide in advanced soft tissue sarcomas. A multicentre phase II study of the EORTC Soft Tissue and Bone Sarcoma Group, EUR J CANC, 36(1), 2000, pp. 61-67
Authors:
Wylie, JP
Cowan, RA
Radford, JA
Deakin, DP
Harris, M
Wilkinson, PM
Citation: Jp. Wylie et al., A doxorubicin-based regimen used in the treatment of elderly patients withhigh-grade non-Hodgkin's lymphoma, CL ONCOL-UK, 12(3), 2000, pp. 153-157
Authors:
Crawley, CR
Foran, JM
Gupta, RK
Rohatiner, AZS
Summers, K
Matthews, J
Micallef, INM
Radford, JA
Johnson, SA
Johnson, PW
Sweetenham, JW
Lister, TA
Citation: Cr. Crawley et al., A phase II study to evaluate the combination of fludarabine, mitoxantrone and dexamethasone (FMD) in patients with follicular lymphoma, ANN ONCOL, 11(7), 2000, pp. 861-865
Authors:
Shamash, J
Lee, SM
Radford, JA
Rohatiner, AZS
Chang, J
Morgenstern, GR
Scarffe, JH
Deakin, DP
Lister, TA
Citation: J. Shamash et al., Patterns of relapse and subsequent management following high-dose chemotherapy with autologous haematopoietic support in relapsed or refractory Hodgkin's lymphoma: A two centre study, ANN ONCOL, 11(6), 2000, pp. 715-719
Authors:
Radford, JA
Citation: Ja. Radford, Is prevention of sterility possible in men?, ANN ONCOL, 11, 2000, pp. 173-174
Authors:
Vose, JM
Wahl, RL
Saleh, M
Rohatiner, AZ
Knox, SJ
Radford, JA
Zelenetz, AD
Tidmarsh, GF
Stagg, RJ
Kaminski, MS
Citation: Jm. Vose et al., Multicenter phase II study of iodine-131 tositumomab for chemotherapy-relapsed/refractory low-grade and transformed low-grade B-cell non-Hodgkin's lymphomas, J CL ONCOL, 18(6), 2000, pp. 1316-1323
Authors:
Foran, JM
Rohatiner, AZS
Cunningham, D
Popescu, RA
Solal-Celigny, P
Ghielmini, M
Coiffier, B
Johnson, PWM
Gisselbrecht, C
Reyes, F
Radford, JA
Bessell, EM
Souleau, B
Benzohra, A
Lister, TA
Citation: Jm. Foran et al., European phase II study of rituximab (chimeric anti-CD20 monoclonal antibody) for patients with newly diagnosed mantle-cell lymphoma and previously treated mantle-cell lymphoma, immunocytoma, and small B-cell lymphocytic lymphoma, J CL ONCOL, 18(2), 2000, pp. 317-324
Authors:
Howell, SJ
Radford, JA
Adams, JE
Shalet, SM
Citation: Sj. Howell et al., The impact of mild Leydig cell dysfunction following cytotoxic chemotherapy on bone mineral density (BMD) and body composition, CLIN ENDOCR, 52(5), 2000, pp. 609-616
Authors:
Howell, SJ
Radford, JA
Smets, EMA
Shalet, SM
Citation: Sj. Howell et al., Fatigue, sexual function and mood following treatment for haematological malignancy: the impact of mild Leydig cell dysfunction, BR J CANC, 82(4), 2000, pp. 789-793
Authors:
Radford, JA
Shalet, SM
Lieberman, BA
Citation: Ja. Radford et al., Fertility after treatment for cancer - Question remain over ways of preserving ovarian and testicular tissue, BR MED J, 319(7215), 1999, pp. 935-936
Authors:
Shipp, MA
Abeloff, MD
Antman, KH
Carroll, G
Hagenbeek, A
Loeffler, M
Montserrat, E
Radford, JA
Salles, G
Schmitz, N
Symann, M
Armitage, JO
Coiffier, B
Philip, T
Citation: Ma. Shipp et al., International Consensus Conference on High-Dose Therapy with HematopoieticStem-Cell Transplantation in Aggressive Non-Hodgkin's Lymphomas: Report ofjury, ANN ONCOL, 10(1), 1999, pp. 13-19
Authors:
Bradley, AJ
Carrington, BM
Lawrance, JAL
Ryder, WDJ
Radford, JA
Citation: Aj. Bradley et al., Assessment and significance of mediastinal bulk in Hodgkin's disease: Comparison between computed tomography and chest radiography, J CL ONCOL, 17(8), 1999, pp. 2493-2498
Authors:
Howell, SJ
Radford, JA
Ryder, WDJ
Shalet, SM
Citation: Sj. Howell et al., Testicular function after cytotoxic chemotherapy: Evidence of Leydig cell insufficiency, J CL ONCOL, 17(5), 1999, pp. 1493-1498
Authors:
Foran, JM
Rohatiner, AZS
Coiffier, B
Barbui, T
Johnson, SA
Hiddemann, W
Radford, JA
Norton, AJ
Tollerfield, SM
Wilson, MP
Lister, TA
Citation: Jm. Foran et al., Multicenter phase II study of fludarabine phosphate for patients with newly diagnosed lymphoplasmacytoid lymphoma, Waldenstrom's macroglobulinemia, and mantle-cell lymphoma, J CL ONCOL, 17(2), 1999, pp. 546-553
Authors:
Shipp, MA
Abeloff, MD
Antman, KH
Carroll, G
Hagenbeek, A
Loeffler, M
Montserrat, E
Radford, JA
Salles, G
Schmitz, N
Symann, M
Armitage, JO
Philip, T
Coiffier, B
Citation: Ma. Shipp et al., International consensus conference on high-dose therapy with hematopoieticstem cell transplantation in aggressive non-hodgkin's lymphomas: Report ofthe jury, J CL ONCOL, 17(1), 1999, pp. 423-429
Authors:
Lee, SM
Ryder, WDJ
Clemons, MJ
Morgenstern, GR
Chang, J
Scarffe, JH
Radford, JA
Citation: Sm. Lee et al., Treatment outcome and prognostic factors for relapse after high-dose chemotherapy and peripheral blood stem cell rescue for patients with poor risk high grade non-Hodgkin's lymphoma, BONE MAR TR, 24(3), 1999, pp. 271-277
Authors:
Taylor, GM
Gokhale, DA
Crowther, D
Wolf, PJ
Harris, M
Ryder, D
Ayres, M
Radford, JA
Citation: Gm. Taylor et al., Further investigation of the role of HLA-DPB1 in adult Hodgkin's disease (HD) suggests an influence on susceptibility to different HD subtypes, BR J CANC, 80(9), 1999, pp. 1405-1411
Authors:
Sengupta, PS
Jayson, GC
Slade, RJ
Eardley, A
Radford, JA
Citation: Ps. Sengupta et al., An audit of primary surgical treatment for women with ovarian cancer referred to a cancer centre, BR J CANC, 80(3-4), 1999, pp. 444-447
Risultati:
1-23
|